National Blood and Cancer Center - NBCC

What National Blood and Cancer Center - NBCC does

The National Blood and Cancer Center (NBCC) is a private, specialty medical institution headquartered in Riyadh, Kingdom of Saudi Arabia, established in 2011 as the first comprehensive center dedicated to the diagnosis and treatment of blood diseases and cancer in the Kingdom. The center operates an integrated hematology and oncology care continuum delivered through two anchor clinics (Oncology Clinic and Hematology Clinic) and supported by diagnostic services (Advanced Imaging Scans including MRI, CT, X-ray, and Bone Density; Advanced Laboratories with genetic testing; Preventive Analyses), treatment services (Chemotherapy, Radiation Therapy, a Treatment Unit with specially trained nurses, and a Treatment Preparation Unit for chemotherapy compounding), and supportive care services (Medical Home Care and Therapeutic Nutrition). NBCC holds dual accreditation from Joint Commission International (JCI) and the Saudi Center for Accreditation of Health Facilities (CBAHI), and is staffed by subspecialists with 15 years of experience, including a Head of Hematology Department, multiple Oncology and Hematology Consultants, and Pediatric Hematology/Oncology Consultants. The center is operated by Al-Wisam Medical Holding Company.

NBCC generates revenue through professional service fees across consultations, diagnostics, chemotherapy, radiation therapy, and bone marrow transplantation, billed primarily through a network of 14+ insurance providers including Bupa, Tawuniya, Malath, SAICO, Al Rajhi Takaful, GlobeMed, Nextcare, Amana, Buruj, Arabian Shield, Medgulf, Al-Etihad, and Salama, supplemented by direct pay and a financial assistance program for distressed patients coordinated with licensed health associations. Patient acquisition is sales-led, driven through direct booking via a bilingual website (bloodandcancer.org), phone (920010693), and WhatsApp, plus a doctor referral platform and recurring community outreach events (such as the annual Pink Ribbon '\u062e\u0637\u0648\u062a\u0643' breast cancer awareness campaign held at corporate, university, and government venues). The center operates a single Riyadh location with defined hours (Saturday 8 AM–5 PM; Sunday–Thursday 8 AM–9 PM; Friday closed) and no disclosed international footprint.

The strategic posture is partnership-driven growth: NBCC has signed agreements in 2024 with Siemens Medical Devices (equipment), Dr. Sulaiman Al Habib Medical Group (clinical collaboration), and Madiha Hospital (service expansion), and in October 2025 with McLaren Medical USA to establish a new specialized hospital in Riyadh under the Al-Wisam Medical Holding umbrella. Customer concentration is structurally low given the individual-patient model and diversified insurance payer mix, while geographic concentration is entirely Riyadh-domestic. The center has no disclosed AI/ML capability, no funding rounds, no M&A history beyond partnership agreements, and no public financials, which limits external valuation visibility.

Name

National Blood and Cancer Center - NBCC

Legal name

National Blood and Cancer Center

Website

https://bloodandcancer.org

Company type

Private

Founded year

2011

Operating status

Operating

Short description

The National Blood and Cancer Center (NBCC) is a private Riyadh-based specialty medical center, established in 2011 as the first comprehensive hematology and oncology facility in Saudi Arabia. It serves adult and pediatric blood disease and cancer patients with an integrated diagnostic, treatment, and supportive care continuum, billing through 14+ insurance networks under Al-Wisam Medical Holding Company.

Ownership category

akta.pro rank

Product category

Specialty Hematology and Oncology Healthcare Services

NAICS

Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621), Medical and Diagnostic Laboratories (62151)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Hematology oncology care
• Cancer treatment services
• Blood disease diagnostics
• Chemotherapy radiation therapy
• Bone marrow transplantation

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Consultations and Treatment Services: NBCC generates revenue through consultation fees (booking via website, phone, or WhatsApp), diagnostic imaging, laboratory tests, chemotherapy, radiation therapy, bone marrow transplantation, and other specialized treatments for blood diseases and cancer patients.
2. Insurance Billing: The center accepts 14+ insurance providers including Bupa, Tawuniya, Malath, SAICO, Al Rajhi Takaful, GlobeMed, Nextcare, Amana, Buruj, Arabian Shield, Medgulf, Al-Etihad, and Salama, billing consultations and treatments through these networks.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

National Blood and Cancer Center (NBCC) is a private specialized medical institution that diagnoses and treats blood diseases (hematology) and cancers (oncology) in adults and children. Its core services include oncology and hematology clinics, advanced imaging scans (MRI, CT, X-ray, Bone Density), advanced laboratory and genetic testing, chemotherapy, radiation therapy, bone marrow transplantation, a treatment unit with specially trained nursing staff, a chemotherapy preparation unit, medical home care, and therapeutic nutrition.

Product overview

NBCC operates as a specialized medical center providing integrated hematology and oncology healthcare services. The core offerings include Oncology Clinic and Hematology Clinic as the primary service lines, supported by diagnostic services (Advanced Imaging Scans, Advanced Laboratories, Preventive Analyzes), treatment services (Chemotherapy, Radiation Therapy, Treatment Unit, Treatment Preparation Unit), and care services (Medical Home Care, Therapeutic Nutrition). All services are designed to work together as a comprehensive patient care continuum from diagnosis through treatment and ongoing follow-up care.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Clinic Provides modern techniques for diagnosing and treating tumors and cancers at various stages using radiology, ultrasound, MRI, and laboratory analysis to determine tumor type, size, and location, with treatment plans developed by specialized medical teams and periodic patient follow-up.
• Hematology Clinic Meticulously diagnoses blood diseases through specialized laboratory tests including blood tests, histological, genetic, and immunological samples, with customized treatment plans including chemotherapy and bone marrow transplantation.
• Advanced Imaging Scans Advanced medical imaging techniques including bone density scans, CT scans, X-rays, and magnetic resonance imaging for diagnosing and evaluating diseases at various stages.
• Advanced Laboratories Provides a wide variety of tests on all sample types including highly sophisticated genetic tests at world-class accuracy and speed levels.
• Preventive Analyzes Uses the latest analysis technology to detect tumors in early stages as a modern means of detection and prevention of tumors for the general public.
• Chemotherapy Delivered by specialized and experienced medical teams for various types and stages of cancers, with doses precisely tailored to each patient's needs and periodically adjusted based on health status and treatment response.
• Radiation Therapy Provides the latest unit of advanced radiology to ensure patient comfort and treatment speed, based on accurate and high-quality diagnostic tests.
• Treatment Unit Provides chemotherapy and complementary therapies for cancer and blood disease patients with specially trained nursing staff and psychosocial support services for patients and families.
• Treatment Preparation Unit Prepares and stores chemotherapy according to physician instructions and patient-specific dosages under special conditions to maintain quality and effectiveness.
• Medical Home Care Provides preventive, rehabilitative, educational, and therapeutic services at patients' homes commensurate with their health, psychological, and social needs, with family participation in treatment plans.
• Therapeutic Nutrition Plays a crucial role in boosting immune systems and strengthening bodies to fight cancer and blood diseases through nutrient-rich foods, vitamins, minerals, and antioxidant foods that combat cancer cells.

Quantifiable outcome

• Dual accreditation from JCI (Joint Commission International) and CBAHI demonstrates compliance with global and Saudi healthcare quality standards.
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered flagship, core and minor.

• McLaren Medical USAflagshipStrategic or Co-development Partner · 1 October 2025Al-Wisam Medical Holding Company (operator of NBCC) signed a strategic partnership agreement with McLaren Medical USA to establish a specialized hospital for the treatment of blood diseases and cancer in Riyadh. The partnership aims to enhance specialized healthcare services in the Kingdom by combining local and international expertise.
• Siemens Medical Devices CompanycoreTechnology or IntegrationNBCC signed a partnership agreement with Siemens for medical devices. Siemens is a global leader in medical technology and imaging solutions.
• Madiha Hospital (مستشفى مديدة)coreStrategic or Co-development PartnerNBCC signed a strategic partnership agreement with Madiha Hospital to enhance healthcare services and expand access to specialized treatment for blood diseases and cancer patients.
• Dr. Sulaiman Al Habib Medical GroupcoreStrategic or Co-development PartnerNBCC signed a strategic partnership agreement with Dr. Sulaiman Al Habib Medical Group to collaborate on healthcare services and treatment of blood diseases and cancer.
• Al-Wisam Medical Holding CompanyflagshipOthersAl-Wisam Medical Holding Company is the parent organization that operates NBCC. It manages the center's strategic direction and has recently partnered with McLaren Medical USA to establish a specialized hospital.
• Maras Medical Company (شركة مراس الطبية)minorGTM or Marketing PartnerNBCC organized a health awareness and early detection event in collaboration with Maras Medical Company for its employees and visitors, featuring an oncology consultation lecture by Dr. Nashwa Abdelaziz and clinical examinations.
• Ministry of Municipal and Rural Affairs and Housing (الministry of البلديات والإسكان)minorGTM or Marketing PartnerNBCC participated in a comprehensive awareness day at the Ministry of Municipal and Rural Affairs and Housing as part of the breast cancer awareness campaign 'تطمينك'.
• Princess Nourah University (جامعة الأميرة نورة)minorGTM or Marketing PartnerNBCC held a comprehensive health awareness event at Princess Nourah University as part of the breast cancer awareness campaign 'خطوتك' to raise awareness about breast cancer.
• Mot'afa Foundation (جمعية متعافي)minorGTM or Marketing PartnerNBCC collaborated with the Mot'afa Foundation (Mot'afa Health Foundation) on the breast cancer awareness campaign 'تطمينك' to present a comprehensive awareness day at the Ministry of Municipal and Rural Affairs and Housing.
• Samsung Saudi ArabiaminorGTM or Marketing PartnerNBCC conducted its October Pink Ribbon initiative 'خطوتك' awareness event at Samsung's Saudi Arabia headquarters, including breast cancer education lectures and clinical examinations.
• AlWisam Golf Club (السعوي جولف)minorGTM or Marketing PartnerNBCC held its October Pink Ribbon 2025 initiative 'خطوتك' awareness event at AlWisam Golf Club, including breast cancer education lectures and clinical examinations.

Scale indicators2 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• National Guard Health Affairs (NGHA) — Oncology Center: Saudi government health system operating large specialty hospitals with oncology and hematology centers in Riyadh and other cities, competing for complex cancer cases and serving as a major referral alternative.
• King Saud Medical City (KSMC) — Oncology Department: Major Riyadh-based public specialty hospital with an established oncology and hematology department that competes for both Saudi nationals and insured patients seeking lower-cost specialty cancer care.
• King Faisal Specialist Hospital and Research Centre (KFSH): Saudi Arabia's flagship tertiary specialty hospital with a major oncology and hematology center, directly competing with NBCC for high-acuity cancer and blood disease cases in Riyadh and across KSA.
• King Abdullah Medical City (KAMC): Large Saudi government specialty hospital in Makkah with comprehensive oncology and hematology services, competing with NBCC for complex cancer cases and serving as an alternative tertiary referral center in KSA.
• Saudi Oncology Center — King Fahad Medical City: Riyadh-based government specialty facility with a dedicated oncology center, providing another local public-sector alternative for hematology/oncology treatment and competing for insured and self-pay referrals.

Broad incumbents

• Saudi German Hospital Group: Major Saudi private multi-specialty hospital network with oncology departments, offering comparable hematology/oncology services at scale across KSA and competing for insured patient volume.
• Dr. Sulaiman Al Habib Medical Group: Largest private Saudi multi-specialty hospital group with extensive oncology and hematology services across multiple cities; an NBCC partner but also a direct competitor for premium specialty cancer patients.

Regional players

• Cleveland Clinic Abu Dhabi: UAE-based tertiary specialty hospital with a well-established oncology program, competing with NBCC for GCC patients willing to travel for premium hematology/oncology care within the regional Gulf market.
• Burjeel Hospital (VPS Healthcare): UAE-headquartered private hospital group with oncology and hematology services across the GCC, comparable in positioning as a premium private specialty provider targeting insured regional patients.

Emerging players

• HCG (HealthCare Global Enterprises): India-listed specialty oncology hospital chain operating a hub-and-spoke cancer-care model across emerging markets; directly comparable in business model and service mix to NBCC's specialty oncology positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nbccksa
• Facebookfacebook.com/NBCCksa
• LinkedInlinkedin.com/company/nbccksa
• Instagraminstagram.com/nbccksa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Blood and Cancer Center - NBCC